InvestorsHub Logo
Followers 23
Posts 3662
Boards Moderated 0
Alias Born 01/02/2003

Re: Alexulf post# 117

Wednesday, 11/22/2017 9:00:13 AM

Wednesday, November 22, 2017 9:00:13 AM

Post# of 451
Management announces expansion plans to meet demands.
Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQB: LDSYF) and (Frankfurt: LD6, WKN: A14XHT) ("LDS" or the "Company") announces that on November 16, 2017, the Company submitted plans for a cultivation facility to be developed on the Company's ten acre parcel to the city of Adelanto planning department. The proposed 202,500 square foot cultivation facility will be an environmentally controlled hybrid greenhouse capable of producing over 150,000 mature cannabis plants from seedlings every 100 days. The Company plans to subdivide the facility which will be leased to permitted and licensed cultivation entities that meet the Company's strict requirements. The Company anticipates receiving the construction permits in time for construction to commence before the end of its fiscal 2017.
Brad Eckenweiler, CEO of LDS, stated, "This facility will represent approximately 20% of the raw cannabis material required to meet the manufacturing, extraction and distillation requirements of CSPA and LDS Scientific. We will continue pursuing qualified contract growers for our product-specific cannabis genetics grow program. This will be necessary to meet the additional raw material needs of the manufacturing facility as well as our continued dependence on current northernCalifornia growers producing high grade contaminate free material." The LDS Scientific's team anticipates releasing production and sales figures generated from November in early December.
About Lifestyle Delivery Systems Inc.
The Company's technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to smoking, but also a new way to accurately meter the dosage and assure the purity of the product. In addition, with the entering into its management services agreements with NHMC, Inc. and CSPA Group, Inc., the Company has begun its direct involvement in the growing of medicinal ingredients for, and the manufacturing of, its products. From seed to sale, the Company's products and ingredients will be tested for quality and composition throughout the formulation and production processes, resulting in a delivery system that is safe, consistent and effective."